WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Long-term disruption of day/night rhythms increases risk of breast cancer and leads to gain in bodyweight Long-term disruption of day/night rhythms leads to an increase in breast cancer risk and bodyweight in mice susceptible to breast cancer.
High number of tick bites expected this summer It is expected that over the coming month, around half a million people will be bitten by a tick. Last month, considerably more tick bites have been reported compared to previous years.
Gardner Middlebrook Award 2015 to Dick van Soolingen RIVM congratulates Professor Dick van Soolingen, who was presented the highly coveted Gardner Middlebrook Award.
Annual report RIVM 2014 online In our annual report, we look back at compelling RIVM projects and research in 2014.
Marc Bonten appointed as new top scientist at RIVM On 1 July, Prof. Dr Marc Bonten, Clinical Microbiologist, took office as a top academic staff member at the RIVM Centre for Infectious Disease Control.
National Heat Plan active The National Heat Plan became active in the Netherlands on June 30th. This means that it is necessary to take preventive health measures for vulnerable groups.
Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands? Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.